The production of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, involves a complex several-stage organic process. Preliminary routes focused on amino acid chain fragment coupling, utilizing solid-phase production methodologies to build the long protein sequence. Subsequent investigation has explored alternative approac